DE69609585D1 - Moleküle, die sich in ausgewählten Organen oder Geweben invivo Einfinden und Verfahren zu ihrer Identifizierung - Google Patents
Moleküle, die sich in ausgewählten Organen oder Geweben invivo Einfinden und Verfahren zu ihrer IdentifizierungInfo
- Publication number
- DE69609585D1 DE69609585D1 DE69609585T DE69609585T DE69609585D1 DE 69609585 D1 DE69609585 D1 DE 69609585D1 DE 69609585 T DE69609585 T DE 69609585T DE 69609585 T DE69609585 T DE 69609585T DE 69609585 D1 DE69609585 D1 DE 69609585D1
- Authority
- DE
- Germany
- Prior art keywords
- molecules
- methods
- organ
- vivo
- tissues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000000056 organ Anatomy 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 238000001727 in vivo Methods 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5067—Liver cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
- G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52670895A | 1995-09-11 | 1995-09-11 | |
US08/526,710 US5622699A (en) | 1995-09-11 | 1995-09-11 | Method of identifying molecules that home to a selected organ in vivo |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69609585D1 true DE69609585D1 (de) | 2000-09-07 |
DE69609585T2 DE69609585T2 (de) | 2001-04-05 |
Family
ID=27062186
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69637395T Expired - Lifetime DE69637395T2 (de) | 1995-09-11 | 1996-09-10 | Moleküle, die sich in ausgewählten Organen oder Geweben in-vivo einfinden |
DE69609585T Expired - Lifetime DE69609585T2 (de) | 1995-09-11 | 1996-09-10 | Moleküle, die sich in ausgewählten Organen oder Geweben invivo Einfinden und Verfahren zu ihrer Identifizierung |
DE0773441T Pending DE773441T1 (de) | 1995-09-11 | 1996-09-10 | Moleküle, die sich in ausgewählten Organen oder Geweben invivo Einfinden und Verfahren zu ihrer Identifizierung |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69637395T Expired - Lifetime DE69637395T2 (de) | 1995-09-11 | 1996-09-10 | Moleküle, die sich in ausgewählten Organen oder Geweben in-vivo einfinden |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE0773441T Pending DE773441T1 (de) | 1995-09-11 | 1996-09-10 | Moleküle, die sich in ausgewählten Organen oder Geweben invivo Einfinden und Verfahren zu ihrer Identifizierung |
Country Status (9)
Country | Link |
---|---|
EP (3) | EP0773441B1 (de) |
JP (3) | JP3900305B2 (de) |
AT (2) | ATE195181T1 (de) |
AU (1) | AU693723B2 (de) |
CA (1) | CA2204535C (de) |
DE (3) | DE69637395T2 (de) |
ES (1) | ES2299232T3 (de) |
HK (1) | HK1027820A1 (de) |
WO (1) | WO1997010507A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69734887T2 (de) * | 1996-09-10 | 2006-08-24 | The Burnham Institute, La Jolla | Tumor findende moleküle, davon abstammende konjugate und verfahren zu deren verwendung |
US6576239B1 (en) | 1996-09-10 | 2003-06-10 | The Burnham Institute | Angiogenic homing molecules and conjugates derived therefrom |
US6361938B1 (en) * | 1996-11-08 | 2002-03-26 | Elan Corporation, Plc | Peptides which enhance transport across tissues and methods of identifying and using the same |
SE9700291D0 (sv) | 1997-01-31 | 1997-01-31 | Pharmacia & Upjohn Ab | Selection method and prodcts resulting therefrom |
AU6682598A (en) * | 1997-03-04 | 1998-09-22 | Bio-Technology General Corporation | Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs |
AU9477398A (en) * | 1997-09-10 | 1999-03-29 | Burnham Institute, The | Methods of identifying molecules that home to angiogenic vasculature in tumors |
US6180084B1 (en) | 1998-08-25 | 2001-01-30 | The Burnham Institute | NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same |
WO1999046284A2 (en) | 1998-03-13 | 1999-09-16 | The Burnham Institute | Molecules that home to various selected organs or tissues |
US6174687B1 (en) | 1999-02-26 | 2001-01-16 | The Burnham Institute | Methods of identifying lung homing molecules using membrane dipeptidase |
AU3545399A (en) * | 1998-04-08 | 1999-10-25 | G.D. Searle & Co. | Dual avb3 and metastasis-associated receptor ligands |
US6852318B1 (en) | 1998-05-08 | 2005-02-08 | The Regents Of The University Of California | Methods for detecting and inhibiting angiogenesis |
WO2000014215A1 (de) * | 1998-09-07 | 2000-03-16 | Eberhard-Karls-Universität Tübingen | Verfahren zur selektion von peptiden für zielgerichteten pharma- und markertransport und peptide damit entdeckt |
DE19845251A1 (de) * | 1998-09-07 | 2000-03-09 | Univ Eberhard Karls | Peptide für Pharmatargeting |
US6528481B1 (en) | 1999-02-16 | 2003-03-04 | The Burnam Institute | NG2/HM proteoglycan-binding peptides that home to angiogenic vasculature and related methods |
US6303573B1 (en) | 1999-06-07 | 2001-10-16 | The Burnham Institute | Heart homing peptides and methods of using same |
EP1212619B1 (de) | 1999-09-14 | 2007-05-23 | Xenoport, Inc. | Substrate und screeningverfahren für transportproteine |
US7037706B1 (en) | 1999-09-29 | 2006-05-02 | Xenoport, Inc. | Compounds displayed on replicable genetic packages and methods of using same |
EP1224327A4 (de) | 1999-09-29 | 2004-09-08 | Xenoport Inc | Zusammensetzungen auf genetisch replizierbaren produkten und methoden zu deren verwendung |
JP2003516745A (ja) * | 1999-12-13 | 2003-05-20 | ケンブリッジ アンティボディー テクノロジー リミティド | 脳特定結合性メンバー |
JP5043271B2 (ja) | 2000-04-12 | 2012-10-10 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | ペプチドベースの化合物 |
US20040170955A1 (en) | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
EP1322755B1 (de) * | 2000-09-08 | 2010-08-18 | Board of Regents, The University of Texas System | Durch phagendisplay identifizierte zielpeptide des menschen und der maus |
US7452964B2 (en) | 2001-09-07 | 2008-11-18 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
US7420030B2 (en) | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
NO20004795D0 (no) | 2000-09-26 | 2000-09-26 | Nycomed Imaging As | Peptidbaserte forbindelser |
AU2002258602A1 (en) | 2001-03-21 | 2002-10-08 | Xenoport, Inc. | Compounds displayed on icosahedral phage and methods of using same |
IL159310A0 (en) | 2001-07-10 | 2004-06-01 | Amersham Health As | Peptide-based compounds |
AU2002319613A1 (en) * | 2001-07-19 | 2003-03-03 | Signet Laboratories, Inc. | Human tissue specific drug screening procedure |
WO2003040693A2 (en) * | 2001-11-08 | 2003-05-15 | The Burnham Institute | Peptides that home to tumor lymphatic vasculature and methods of using same |
US7192921B2 (en) | 2001-11-08 | 2007-03-20 | The Burnham Institute | Peptides that home to tumor lymphatic vasculature and methods of using same |
US7544767B2 (en) | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
GB0210538D0 (en) * | 2002-05-08 | 2002-06-19 | Univ London | Lipids and gene delivery |
US7598341B2 (en) | 2003-10-31 | 2009-10-06 | Burnham Institue For Medical Research | Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs |
CA2461223C (en) * | 2004-03-16 | 2013-05-28 | Stanley Phillips | Apparatus for generating ozone and/or o1 using a high energy plasma discharge |
CA2593964A1 (en) | 2004-12-23 | 2006-06-29 | Molmed Spa | Conjugation product |
NZ569818A (en) | 2005-12-16 | 2012-07-27 | Catherine M Shachaf | Diagnostic system for the detection and diagnosis of skin cancer |
FI121959B (fi) * | 2008-05-09 | 2011-06-30 | Pirjo Laakkonen | Aivokasvaimiin hakeutuva peptidi |
JP5522717B2 (ja) * | 2008-09-19 | 2014-06-18 | 国立大学法人佐賀大学 | アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法 |
JP2012513589A (ja) | 2008-12-23 | 2012-06-14 | ジーイー・ヘルスケア・リミテッド | 骨髄イメージング剤としての99mTc−ペプチド系化合物の応用 |
US10322189B2 (en) | 2014-11-12 | 2019-06-18 | University Of Mississippi Medical Center | Kidney-targeted drug delivery systems |
US11564991B2 (en) | 2014-11-12 | 2023-01-31 | University Of Mississippi Medical Center | Molecular-size of elastin-like polypeptide delivery system for therapeutics modulates intrarenal deposition and bioavailability |
US20190022239A1 (en) * | 2016-01-19 | 2019-01-24 | The University Of Western Australia | Novel biomolecule conjugates and uses therefor |
AU2017273169B2 (en) * | 2016-06-03 | 2020-07-30 | Aimed Bio Inc. | Method for screening antibody using patient-derived tumor spheroids |
US11248038B2 (en) | 2019-03-29 | 2022-02-15 | University Of Mississippi Medical Center | Molecular-size of elastin-like polypeptide delivery system for therapeutics modulates intrarenal deposition and bioavailability |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE23169T1 (de) * | 1983-07-21 | 1986-11-15 | Scripps Clinic Res | Synthetische polypeptide, die gehirnspezifischen mrnas translatierten proteinoidabschnitten entsprechen, sowie ihre anwendung fuer rezeptoren, methoden und diagnostik. |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5650489A (en) * | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
WO1992003461A1 (en) * | 1990-08-24 | 1992-03-05 | Ixsys, Inc. | Methods of synthesizing oligonucleotides with random codons |
US5264563A (en) * | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
AU8740491A (en) * | 1990-09-28 | 1992-04-28 | Protein Engineering Corporation | Proteinaceous anti-dental plaque agents |
IL106106A0 (en) * | 1993-06-22 | 1993-10-20 | Interpharm Lab Ltd | Library of polymeric molecules and its preparation |
US5981478A (en) * | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
-
1996
- 1996-09-10 EP EP96250195A patent/EP0773441B1/de not_active Expired - Lifetime
- 1996-09-10 ES ES99250432T patent/ES2299232T3/es not_active Expired - Lifetime
- 1996-09-10 JP JP51208797A patent/JP3900305B2/ja not_active Expired - Fee Related
- 1996-09-10 CA CA002204535A patent/CA2204535C/en not_active Expired - Fee Related
- 1996-09-10 EP EP96930824A patent/EP0876611A1/de not_active Ceased
- 1996-09-10 AU AU69739/96A patent/AU693723B2/en not_active Ceased
- 1996-09-10 AT AT96250195T patent/ATE195181T1/de active
- 1996-09-10 DE DE69637395T patent/DE69637395T2/de not_active Expired - Lifetime
- 1996-09-10 DE DE69609585T patent/DE69609585T2/de not_active Expired - Lifetime
- 1996-09-10 WO PCT/US1996/014600 patent/WO1997010507A1/en not_active Application Discontinuation
- 1996-09-10 DE DE0773441T patent/DE773441T1/de active Pending
- 1996-09-10 AT AT99250432T patent/ATE382630T1/de not_active IP Right Cessation
- 1996-09-10 EP EP99250432A patent/EP0987275B1/de not_active Expired - Lifetime
-
2000
- 2000-09-22 HK HK00106023A patent/HK1027820A1/xx not_active IP Right Cessation
-
2002
- 2002-08-26 JP JP2002245801A patent/JP2003155296A/ja active Pending
-
2007
- 2007-03-06 JP JP2007056453A patent/JP2007204483A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0773441A1 (de) | 1997-05-14 |
EP0987275B1 (de) | 2008-01-02 |
EP0987275A2 (de) | 2000-03-22 |
WO1997010507A1 (en) | 1997-03-20 |
ATE195181T1 (de) | 2000-08-15 |
HK1027820A1 (en) | 2001-01-23 |
CA2204535A1 (en) | 1997-03-20 |
JPH10502674A (ja) | 1998-03-10 |
DE69637395T2 (de) | 2008-12-18 |
ES2299232T3 (es) | 2008-05-16 |
JP2007204483A (ja) | 2007-08-16 |
ATE382630T1 (de) | 2008-01-15 |
EP0987275A3 (de) | 2006-06-21 |
JP2003155296A (ja) | 2003-05-27 |
AU693723B2 (en) | 1998-07-02 |
JP3900305B2 (ja) | 2007-04-04 |
CA2204535C (en) | 2002-11-12 |
EP0876611A1 (de) | 1998-11-11 |
DE69609585T2 (de) | 2001-04-05 |
DE69637395D1 (de) | 2008-02-14 |
AU6973996A (en) | 1997-04-01 |
DE773441T1 (de) | 1999-03-04 |
EP0773441B1 (de) | 2000-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69609585T2 (de) | Moleküle, die sich in ausgewählten Organen oder Geweben invivo Einfinden und Verfahren zu ihrer Identifizierung | |
DE69821011D1 (de) | Verfahren zur modulierung der neovaskularisierung und/oder des wachstums von kollateraler arterien und / oder anderer arterien aus bestehenden arteriolären verbindungen | |
MX9709913A (es) | Metaloconstrucciones determinadas estructuralmente y aplicaciones. | |
ATE245940T1 (de) | Automatische biopsieinstrumente | |
ATE239443T1 (de) | Präparat und verfahren zur künstlichen hautbräunung | |
ATE534909T1 (de) | Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren | |
HK1026234A1 (en) | Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs | |
DK1007566T3 (da) | Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf | |
EP2258702A3 (de) | Gereinigte Zusammensetzungen von 10-Propargyl-10-Deazaaminopterin unde Verfahren zu ihrer Verwendung bei der Behandlung von Tumoren | |
ES2187648T3 (es) | Metodo para la administracion de farmacos para terapia genica. | |
DE69811348T2 (de) | Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen | |
ATE417930T1 (de) | Proteinkinase npk-110 | |
WO1998010076A3 (en) | Phospholipase d and dna sequences | |
DE69636041D1 (de) | Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen | |
DE60139150D1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
WO2002034282A3 (en) | Mammary secreted protein 36 (msp36) for cancer treatment and diagnosis | |
ES2192419T3 (es) | Material aislado que presenta un efecto anti-organotrofico. | |
ATE269897T1 (de) | Methoden zur identifizierung und validierung von funktionellen zielen mittels intrameren oder in vivo selektion | |
DE60125754D1 (de) | Mutantenstämme geeignet zur herstellung von chemisch unterschiedlichen proteinen, die nicht-konventionelle aminosäuren enthalten | |
RU98112564A (ru) | Способ восстановления естественных структур и процессов организма, больного при интоксикации | |
FI953364A (fi) | Kehon nesteistä tai kudoksista uutettujen synteettisten oligonukleotidien toteaminen | |
DE10084883D2 (de) | Verfahren zur genetischen Rekonstruktion von menschlichen Organen | |
AU6838400A (en) | Use of colored metal binding proteins |